𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Unfaithfulness and promiscuity of a mutant androgen receptor in a hormone-refractory prostate cancer

✍ Scribed by A. Monge; M. Jagla; G. Lapouge; S. Sasorith; M. Cruchant; J.-M. Wurtz; D. Jacqmin; J.-P. Bergerat; J. Céraline

Publisher
Springer
Year
2006
Tongue
English
Weight
835 KB
Volume
63
Category
Article
ISSN
1420-682X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Androgen receptor gene mutations in horm
Androgen receptor gene mutations in hormone-refractory prostate cancer
✍ Wall�n, Mika J.; Linja, Marika; Kaartinen, Kaius; Schleutker, Johanna; Visakorpi 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB 👁 2 views

Prostate cancer is considered to be one of the most hormone-dependent human malignancies. As a key mediator of hormonal response, the androgen receptor (AR) is believed to have an important role in the progression of prostate cancer. Mutations in the coding region of the AR gene have been found in b

Amplification of the androgen receptor g
Amplification of the androgen receptor gene is associated with P53 mutation in hormone-refractory recurrent prostate cancer
✍ Koivisto, Pasi A.; Rantala, Immo 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 257 KB 👁 2 views

p53 protein expression of 30 hormone-refractory locally recurrent prostate cancers was compared with their matched untreated primary tumour specimens. In addition, androgen receptor (AR) gene amplification and p53 protein immunostaining were compared. p53 positivity increased during hormonal therapy

Androgen receptor gene amplification inc
Androgen receptor gene amplification increases tissue PSA protein expression in hormone-refractory prostate carcinoma
✍ Koivisto, Pasi A.; Helin, Heikki J. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 268 KB 👁 2 views

Androgen receptor (AR) gene amplification was analysed by fluorescence in situ hybridization (FISH) from 24 paraffin-embedded prostate carcinoma samples recurring locally during hormonal therapy and prostate-specific antigen (PSA) expression from 15/24 of these samples was studied by immunohistochem

Androgen receptor: A key molecule in the
Androgen receptor: A key molecule in the progression of prostate cancer to hormone independence
✍ Mary-Ellen Taplin; Steven P. Balk 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 2 views

## Abstract Despite earlier detection and recent advances in surgery and radiation, prostate cancer is second only to lung cancer in male cancer deaths in the United States. Hormone therapy in the form of medical or surgical castration remains the mainstay of systemic treatment in prostate cancer.

Cyclin G-associated kinase: A novel andr
Cyclin G-associated kinase: A novel androgen receptor-interacting transcriptional coactivator that is overexpressed in hormone refractory prostate cancer
✍ Mira R. Ray; Latif A. Wafa; Helen Cheng; Robert Snoek; Ladan Fazli; Martin Gleav 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 518 KB

## Abstract The androgen receptor (AR), a steroid receptor family member, is a ligand‐dependent transcription factor that has an integral role in normal prostate development. Alterations in AR‐mediated activity can result in abnormal gene expression, dysregulated cell growth and prostate cancer. Co

Emergence of metastatic hormone-refracto
Emergence of metastatic hormone-refractory disease in prostate cancer after anti-androgen therapy
✍ Edmund Chun Yu Lee; Martin P.R. Tenniswood 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB

## Abstract The anti‐androgens used in prostate cancer therapy have been designed to interfere with the normal androgen receptor (AR)‐mediated processes that ensure prostate cell survival, triggering tumor cells to undergo programmed cell death. While anti‐androgens were originally designed to trea